-
501
Cardiovascular safety of Janus kinase inhibitors in inflammatory bowel disease: a systematic review and network meta-analysis
Published 2025-12-01Subjects: Get full text
Article -
502
Antiedemic Effect of the Myosin Light Chain Kinase Inhibitor PIK7 in the Rat Model of Myocardial Ischemia Reperfusion Injury
Published 2025-01-01Subjects: Get full text
Article -
503
Bone marrow mesenchymal stem cells derived cytokines associated with AKT/IAPs signaling ameliorate Alzheimer’s disease development
Published 2025-01-01Subjects: Get full text
Article -
504
The road ahead: emerging therapies for primary IgA nephropathy
Published 2025-02-01Subjects: “…SGLT2 (sodium-glucose cotransporter 2) inhibitor…”
Get full text
Article -
505
Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer
Published 2025-01-01Subjects: Get full text
Article -
506
Biomarkers in metastatic castration-resistant prostate cancer for efficiency of immune checkpoint inhibitors
Published 2025-12-01Subjects: Get full text
Article -
507
Sintilimab for treating progressive multifocal leukoencephalopathy caused by human polyomavirus 2 virus infection following allogeneic hematopoietic cell transplantation: a case re...
Published 2025-12-01Subjects: “…programmed death receptor 1 inhibitor…”
Get full text
Article -
508
-
509
Late-onset and relapsed cytokine release syndrome after nivolumab treatment in a patient with head and neck squamous cell carcinoma: a case report
Published 2025-02-01Subjects: “…immune checkpoint inhibitor…”
Get full text
Article -
510
-
511
Changes in levels of urokinase receptor and other components of fibrinolytic system in brain tissues in urokinase gene-knockout mice with B16/F10 melanoma growing together with chr...
Published 2022-03-01Subjects: “…plasminogen activator inhibitor…”
Get full text
Article -
512
-
513
CARDIAC-STAR: prevalence of cardiovascular comorbidities in patients with HR + /HER2 − metastatic breast cancer
Published 2025-01-01Subjects: “…Cyclin-dependent kinase 4/6 inhibitor…”
Get full text
Article -
514
The first experience with sodium‐glucose cotransporter 2 inhibitor for the treatment of systemic right ventricular failure
Published 2022-06-01Subjects: “…Adult congenital heart diseaseChronic heart failureSodium‐glucose cotransporter inhibitor…”
Get full text
Article -
515
From bench to bedside: elucidating VEGF(R) inhibitor-related heart failure in cancer treatment
Published 2025-01-01Subjects: Get full text
Article -
516
Short‐term echocardiographic evaluation by global longitudinal strain in patients with heart failure treated with sacubitril/valsartan
Published 2020-06-01Subjects: “…Angiotensin receptor neprilysin inhibitor…”
Get full text
Article -
517
A comprehensive comparison of PARP inhibitors as maintenance therapy in platinum-sensitive recurrent ovarian cancer: a systematic review and network meta-analysis
Published 2025-01-01Subjects: “…Poly (ADP-ribose) polymerase inhibitor…”
Get full text
Article -
518
Increased serum soluble PD-l1 levels in patients with advanced stages of chronic kidney disease
Published 2025-01-01Subjects: Get full text
Article -
519
-
520
Tousled-like kinase loss confers PARP inhibitor resistance in BRCA1-mutated cancers by impeding non-homologous end joining repair
Published 2025-01-01Subjects: Get full text
Article